Infant Bacterial Therapeutics
Kristina Sjöblom Nygren is on the Board of Directors at Infant Bacterial Therapeutics. Kristina has been Chief Medical Officer, Head of Development, since 2018 at Santhera Pharmaceuticals in Basel, Switzerland. She has extensive experience in the pharmaceutical industry, where she has held among other positions Head of Clinical Development at SOBI.
Kristina received a Doctor of Medical Sciences from Karolinska Institutet and is a licensed physician.
This person is not in the org chart
This person is not in any offices
Infant Bacterial Therapeutics
IBT is a clinical stage pharmaceutical company with a vision to develop drugs influencing the infant microbiome, and thereby prevent or treat rare diseases affecting infants.